Policymakers in low- and middle-income countries are often stymied by a lack of data on the most efficient ways to prioritize health spending. This webinar will explore how standardized data on cost-effectiveness can assist with such decisions, by leveraging the Tufts-CEVR Global Health Cost-Effectiveness Registry and its associated tools. We will also review challenges with the cost-effectiveness literature and identify areas for improvement.
Peter Neumann, ScD, Director, Center for the Evaluation of Value and Risk in Health
Peter Neumann is the Director of CEVR at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Professor of Medicine at Tufts University School of Medicine. He is the founder and director of the Cost-Effectiveness Analysis Registry, a comprehensive database of cost-effectiveness analyses in health care.
Dan Ollendorf, PhD, Director, Value Measurement & Global Health Initiatives, Center for the Evaluation of Value and Risk in Health
Dan Ollendorf is Director of Value Measurement and Global Health Initiatives at CEVR and Assistant Professor of Medicine at Tufts University School of Medicine. Prior to joining CEVR, Dan was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he oversaw the broader HTA process and managed relationships with multiple stakeholders and research collaborators
Kalipso Chalkidou, MD, PhD, Director of Global Health Policy and a Senior Fellow at the Center for Global Development
Kalipso Chalkidou is the Director of Global Health Policy and a Senior Fellow at the Center for Global Development. Previously, she was the Director of Global Health and Development Group at the Institute of Global Health Innovation, Imperial College London, helping governments build technical and institutional capacity for improving the value for money of their healthcare investment.